BDX-CD-003 Altitude: A multicenter randomized controlled trial prospectively evaluating the clnical utility of Nodify XL2 Proteomic Classifier in incendentally low to moderate risk lung nodules

Administered By

Awarded By

Contributors

Start/End

  • August 29, 2020 - August 31, 2026